SCOPUS 정보 검색 플랫폼

Volumn 32, Issue 5, 2000, Pages 1131-1137

Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C

(7) Poynard, Thierry a McHutchison, John b Davis, Gary L c Esteban Mur, Rafael d Goodman, Zachary e Bedossa, Pierre f Albrecht, Janice g

a PITIÉ SALPÊTRIÈRE HOSPITAL (France)

b SCRIPPS RESEARCH INSTITUTE (United States)

c UNIVERSITY OF FLORIDA (United States)

d HOSPITAL UNIVERSITARI VALL D HEBRON (Spain)

e ARMED FORCES INSTITUTE OF PATHOLOGY (United States)

f BICÊTRE HOSPITAL (France)

g MERCK RESEARCH LABORATORIES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; PLACEBO; REBETRON;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0033766167 PISSN: 02709139 EISSN: None Source Type: Journal
DOI: 10.1053/jhep.2000.19347 Document Type: Article

Times cited : (264)

References (28)

1
- 0030955346
- Epidemiology of hepatitis C
- (1997) HEPATOLOGY , Issue.SUPPL. 1 , pp. 62-65
- Alter, M.J.¹

2
- 0031567749
- Hepatitis C: Global prevalence
- (1997) Wkly Epidemiol Rec , vol.72 , pp. 341-344

3
- 0030933395
- DOSVIRC groups Natural history of liver fibrosis progression in patients with chronic hepatitis C
- (1997) Lancet , vol.349 , pp. 825-832
- Poynard, T.¹ Bedossa, P.² Opolon, P.³

4
- 0027050805
- Long-term mortality after transfusion-associated non-A non-B hepatitis
- (1992) N Engl J Med , vol.327 , pp. 1906-1911
- Seeff, L.B.¹ Buskell-Bales, Z.² Wright, E.C.³ Durako, S.J.⁴ Alter, H.J.⁵ Iber, F.L.⁶ Hollinger, F.B.⁷

5
- 0028998145
- Clinical outcomes after transfusion-associated hepatitis C
- (1995) N Engl J Med , vol.332 , pp. 1463-1466
- Tong, M.J.¹ El-Farra, N.S.² Reikes, A.R.³ Co, R.L.⁴

6
- 0031583763
- Mortality from liver cancer and liver disease in haemophilic men and boys given blood products contaminated with hepatitis C
- (1997) Lancet , vol.350 , pp. 1425-1431
- Darby, S.C.¹ Ewart, D.W.² Giangrande, P.L.F.³ Spooner, R.J.⁴ Rizza, C.R.⁵ Dusheiko, G.M.⁶ Lee, C.A.⁷

7
- 0029833829
- Meta-analysis of interferon randomized trials in the treatment of viral hepatitis: Effects of dose and duration
- (1996) HEPATOLOGY , vol.24 , pp. 778-789
- Poynard, T.¹ Leroy, V.² Cohard, M.³ Thevenot, T.⁴ Mathurin, P.⁵ Opolon, P.⁶ Zarski, J.P.⁷

8
- 0030740089
- The effect of interferon in chronic hepatitis C: A quantitative evaluation of histology by meta-analysis
- (1997) J Hepatol , vol.26 , pp. 1187-1199
- Camma, C.¹ Giunta, M.² Linea, C.³ Pagliaro, L.⁴

9
- 0032501714
- Randomised, double-blind, placebo-controlled trial of interferon alfa-2b with and without ribavirin for chronic hepatitis C
- (1998) Lancet , vol.351 , pp. 83-87
- Reichard, O.¹ Norkrans, G.² Fyden, A.³ Braconier, J.H.⁴ Sonnerborg, A.⁵ Weiland, O.⁶

10
- 0032585237
- Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³ Niederau, K.⁴ Minuk, G.S.⁵ Ideo, G.⁶ Bain, V.⁷

11
- 0032547938
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) N Engl J Med , vol.339 , pp. 1485-1492
- McHutshison, J.¹ Gordon, S.² Schiff, E.³ Shiffman, M.L.⁴ Lee, W.M.⁵ Rustgi, V.K.⁶ Goodman, Z.D.⁷

12
- 0032547944
- Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
- (1998) N Engl J Med , vol.339 , pp. 1493-1499
- Davis, G.¹ Esteban-Mur, R.² Rustgi, V.³ Hoers, J.⁴ Gordon, S.C.⁵ Trepo, C.⁶ Shiffman, M.L.⁷

13
- 0032905640
- Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view
- (1999) Gastroenterology , vol.116 , pp. 378-386
- Sobesky, R.¹ Mathurin, P.² Charlotte, F.³ Moussalli, J.⁴ Olivi, M.⁵ Vidaud, M.⁶ Ratziu, V.⁷

14
- 0030634907
- Anti-fibrotic effects of interferons. Mechanisms and therapeutic prospects
- (1997) Gastroenterol Clin Biol , vol.21 , pp. 466-471
- Pilette, C.¹ Fort, J.² Riflet, H.³ Cales, P.⁴

15
- 0000016853
- Molecular action of ribavirin
- (1990) Rev Infect Dis , vol.12 , pp. 1332-1346
- Patterson, J.L.¹ Fernandez-Larson, R.²

16
- 0032055507
- Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response
- (1998) J Immunol , vol.160 , pp. 3487-3493
- Ning, Q.¹ Brown, D.² Parodo, J.³ Cattral, M.⁴ Gorczynski, R.⁵ Cole, E.⁶ Fung, L.⁷

17
- 0019813866
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
- (1981) HEPATOLOGY , vol.1 , pp. 431-435
- Knodell, R.G.¹ Ishak, K.G.² Black, W.C.³ Chen, T.S.⁴ Craig, R.⁵ Kaplowitz, N.⁶ Kiernan, T.W.⁷

18
- 0003179169
- Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C
- (1994) HEPATOLOGY , vol.20 , pp. 15-20

19
- 0029778988
- An algorithm for the grading of activity in chronic hepatitis C
- (1996) HEPATOLOGY , vol.24 , pp. 289-293
- Bedossa, P.¹

20
- 0028134619
- Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin
- (1994) J Gastroenterol Hepatol , vol.9 , pp. 587-591
- Tong, M.J.¹ Hwang, S.J.² Lefkowitz³ Lee, S.D.⁴ Co, R.L.⁵ Conrad, A.⁶ Schmid, P.⁷

21
- 0027178527
- Typing of hepatitis C virus isolates and characterisation of new subtypes using a line probe assay
- (1993) J Gen Virol , vol.74 , pp. 1093-1102
- Stuyver, L.¹ Rossau, R.² Wyseur, A.³ Duhamel, M.⁴ Vanderborght, B.⁵ Van Heuverswyn, H.⁶ Maertens, G.⁷

22
- 0003740794
- Kaysville, Utah
- NCSS 97 User Guide. Number Cruncher Statistical Systems , pp. 1997
- Hintze, J.L.¹

23
- 0026772470
- Long-term follow-up of patients with chronic hepatitis C treated with α-interferon
- (1992) HEPATOLOGY , vol.15 , pp. 1013-1016
- Shindo, M.¹ Di Bisceglie, A.M.² Hoofnagle, J.H.³

24
- 15644380122
- Long-term histologic improvement and loss o f detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy
- (1997) Ann Intern Med , vol.127 , pp. 875-881
- Marcellin, P.¹ Boyer, N.² Gervais, A.³ Martinot, M.⁴ Pouteau, M.⁵ Castelnau, C.⁶ Kilani, A.⁷

25
- 0029054011
- A comparison of three interferon alpha-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis
- (1995) N Engl J Med , vol.332 , pp. 1457-1462
- Poynard, T.¹ Bedossa, P.² Chevalier, M.³ Mathurin, P.⁴ Lemonnier, C.⁵ Trepo, C.⁶ Couzigou, P.⁷

26
- 0032736213
- A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia
- (1999) Gastroenterology , vol.117 , pp. 1164-1172
- Shiffman, M.L.¹ Hofmann, C.M.² Contos, M.J.³ Luketic, V.A.⁴ Sanyal, A.J.⁵ Sterling, R.K.⁶ Ferreira-Gonzalez, A.⁷

27
- 0033965331
- Is an 'a la carte' combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group
- (2000) HEPATOLOGY , vol.31 , pp. 211-218
- Poynard, T.¹ McHutchison, J.² Goodman, Z.³ Ling, M.H.⁴ Albrecht, J.⁵

28
- 0032147073
- Reinforced regimen of interferon alfa 2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: A multicenter randomized trial
- (1998) J Hepatol , vol.29 , pp. 224-232
- Degos, F.¹ Daurat, V.² Chevret, S.³ Gayno, S.⁴ Bastie, A.⁵ Riachi, G.⁶ Bartolomei-Portal, I.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.